Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             23 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Absence of cardiotoxicity with prolonged treatment and large accumulating doses of pegylated liposomal doxorubicin Blank, N.
2017
80 4 p. 737-743
artikel
2 Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis Abdel-Daim, Mohamed M.
2017
80 4 p. 745-753
artikel
3 Antiangiogenic tyrosine kinase inhibitors in colorectal cancer: is there a path to making them more effective? Karasic, Thomas B.
2017
80 4 p. 661-671
artikel
4 A phase II study of modified docetaxel, cisplatin, and S-1 (mDCS) chemotherapy for unresectable advanced gastric cancer Uemura, Naoki
2017
80 4 p. 707-713
artikel
5 A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men Markus, Richard
2017
80 4 p. 755-763
artikel
6 Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value Skubitz, Keith M.
2017
80 4 p. 787-798
artikel
7 Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea Lee, Kyong Joo
2017
80 4 p. 799-805
artikel
8 Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer Tagawa, Nao
2017
80 4 p. 841-849
artikel
9 Comparison of the RECIST and EORTC PET criteria in the tumor response assessment: a pooled analysis and review Kim, Jung Han
2017
80 4 p. 729-735
artikel
10 Continuous low plasma concentrations of everolimus provides equivalent efficacy to oral daily dosing in mouse xenograft models of human cancer Laborde, Laurent
2017
80 4 p. 869-878
artikel
11 Depth of response predicts the clinical outcome of advanced HER2-positive gastric cancer to trastuzumab-based first-line chemotherapy Kadowaki, Shigenori
2017
80 4 p. 807-813
artikel
12 Hyponatremia and V2 vasopressin receptor upregulation: a result of HSP90 inhibition Yang, Qiong
2017
80 4 p. 673-684
artikel
13 Interim analysis of a phase II trial evaluating the safety and efficacy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer Danno, Katsuki
2017
80 4 p. 777-785
artikel
14 MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells Rajabpour, Azam
2017
80 4 p. 765-775
artikel
15 Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia Ben Hassine, Islem
2017
80 4 p. 829-839
artikel
16 Novel formulation of abiraterone acetate might allow significant dose reduction and eliminates substantial positive food effect Solymosi, Tamás
2017
80 4 p. 723-728
artikel
17 Optimism and the continued promise of maintenance chemotherapy Micha, John P.
2017
80 4 p. 879-880
artikel
18 Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma Badruddoja, Michael A.
2017
80 4 p. 715-721
artikel
19 Significance of glucocorticoid receptor expression in patients with non-small cell lung cancer treated with pemetrexed-based chemotherapy Zhao, Xin-min
2017
80 4 p. 851-860
artikel
20 Superactive human leptin antagonist (SHLA), triple Lan1 and quadruple Lan2 leptin mutein as a promising treatment for human folliculoma Fiedor, E.
2017
80 4 p. 815-827
artikel
21 Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition Srinivasan, Gayathri
2017
80 4 p. 861-867
artikel
22 The concept of platinum sensitivity could be applied to recurrent cervical cancer: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group Takekuma, Munetaka
2017
80 4 p. 697-705
artikel
23 Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer Huang, Shengshi
2017
80 4 p. 685-696
artikel
                             23 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland